An effective method to enhance transient gene expression by transfecting high-density CHO cells Authors: Yu-shun Fu, Xue-lian Han, Wei-dong Li, Lin-lin Shan, Shao-lei Geng, Chun-liu Mi, Wei-hua Dong, Tian-yun Wang, Xiao-yin Wang Published: 2025 ABSTRACT Chinese hamster ovary (CHO) cells are the predominant host for recombinant protein production. While transient gene expression (TGE) systems provide a faster, more cost-effective alternative to stable gene expression (SGE), their application is often hampered by low protein yields. Here, we optimized TGE systems based on high-density suspension transfection using 40 kDa polyethylenimine (PEI) by engineering vector regulatory elements (Kozak, polyA, introns, leader) and optimizing transfection conditions. Vector optimization led to a substantial enhancement in recombinant protein, with EGFP and SEAP levels increased by 5.33-fold and 4.13-fold, respectively (p < 0.05). By applying the optimized vector in combination with identified optimal conditions, a DNA concentration of 4 µg/mL, a DNA: PEI mass ratio of 1:5, and a repeated transfection strategy, we achieved a transfection efficiency of 76.34% while maintaining cell viability above 85%. Moreover, the combined optimization of vectors and transfection conditions robustly enhance the production of therapeutically relevant proteins, increased the expression of recombinant type III human collagen and human serum albumin by 4.86-fold and 5.50-fold, respectively (p < 0.05). In summary, high-density suspension transfection markedly boosts transient recombinant protein expression in CHO cells by improving transfection efficiency, expanding the population of recombinant cells, and maintaining high cell viability. This approach presents a promising and effective strategy for high yield transient transgene expression.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13568-025-01999-y. Introduction With the rapid advancement of biotechnology, mammalian cell expression systems have become increasingly prevalent in basic research and the biopharmaceutical industry (Hoseinpoor et al. 2020; Wolnick et al. 2024). Chinese hamster ovary (CHO) cells are a preferred host for recombinant protein production due to their high expression capacity, ability to perform proper protein folding and post-translational modifications, ease of large-scale cultivation, and minimal risk of host-derived protein contamination (Gray 2001; Gupta et al. 2021; Kim et al. 2012; Li et al. 2010; Tihanyi and Nyitray 2020). Although stable gene expression (SGE) systems are widely used, they suffer from long development times and complex procedures. In contrast, transient gene expression (TGE) systems provide a rapid and efficient alternative for expressing the gene of interest (Mariati et al. 2014; Yamaguchi et al. 2025). TGE is characterized by shorter experimental cycles and simpler protocols, making it ideal for rapid gene function screening, small-scale recombinant protein production, and expression condition optimization (Baldi et al. 2007; Pham et al. 2006). However, its broader application is constrained by relatively low transfection efficiency and protein yield. Multiple factors influence recombinant protein expression, including cellular status, transfection parameters, expression vector, and culture conditions (Gutiérrez-Granados et al. 2018; Toporova et al. 2023; Torres and Dickson. 2022; Zhang et al. 2025a). Among these, vector optimization is a well-established and effective strategy. The Kozak sequence enhances translational initiation by improving ribosomal recognition of the start codon AUG, and its efficacy depends on the conservation of core nucleotides (Blanco et al. 2020; Hernández et al. 2019). The polyA signal extends mRNA half-life and facilitates nuclear-to-cytoplasmic transport, thereby boosting protein synthesis (Blø et al. 2008; Passmore et al.2022). Incorporation of introns can enhance recombinant protein expression by 2- to 5-fold by improving mRNA splicing efficiency and promoting nuclear export (Lee et al.2018; Xu et al. 2025). Similarly, a 5′ untranslated region (UTR) leader sequence can enhance ribosome binding, mRNA stability, and translation efficiency (Eisenhut et al. 2020; Spruill and McDermott 2009).Systematically combining these regulatory elements offers a synergistic approach to improving both the efficiency and productivity of recombinant protein production. Beyond vector design, transfection parameters are critical for efficient transient recombinant protein expression. Polyethyleneimine (PEI) is a widely transfection reagent, favored for its high transfection efficiency, low toxicity, and cost-effectiveness (Longo et al. 2013). Furthermore, cell density and culture conditions significantly influence protein expression. The use of high cell densities in PEI-mediated transfection represents a promising strategy to rapidly achieve high protein production (Schmitt et al. 2020; Stuible et al. 2018; Schwarz et al. 2020). Yet, this approach demands precise optimization of transfection conditions. HEK293 cells with 25 kDa PEI are frequently employed in transient expression (da Silva Junior. 2022; de Los Milagros Bassani Molinas et al. 2014; Ding et al. 2017; Hacker et al. 2013). However, HEK293 cells carry a risk of human viral contamination, which limits their application in the production of therapeutic biologics (Delafosse et al. 2016; Durocher et al. 2002). While 25 kDa linear PEI is commonly used in TGE due to its low cytotoxicity, its performance varies significantly between batches (Gabrielson and Pack. 2006; Kadlecova et al. 2012). Moreover, transfection outcomes are strongly influenced by PEI amount and the DNA: PEI mass ratio (Xie et al. 2013; Yang et al. 2017). In this study, we developed a high-efficiency transient expression system based on CHO cells using 40 kDa linear PEI under high-density suspension culture. We systematically optimized vector regulatory elements and identified high performance expression constructs. Additionally, critical transfection parameters, including DNA concentration, DNA/PEI mass ratio, and repeated transfection frequency were fine-tuned. Our results demonstrate that high-density CHO cell transfection with 40 kDa PEI is an effective approach for enhancing transient expression. Materials and methods Plasmids construction The original transient expression vectors pEGFP and pSEAP with enhanced green fluorescent protein (EGFP) / secreted alkaline phosphatase (SEAP), CMV promoter, native intron, Kozak and poly A signal sequences were maintained in our laboratory (Fig. 1A). In previous studies, we identified Kozak, poly A, and intron elements that significantly enhance recombinant protein expression in CHO cells (Li et al. 2024; Wang et al. 2022; Xu et al. 2025). In the present study, we first synthesized the identified Kozak sequences and replaced the native Kozak sequences in the pEGFP and pSEAP using seamless cloning to generate the pEGFP-K and pSEAP-K (Fig. 1B). Subsequently, the identified poly A sequences were synthesized and used to replace the native poly A sequences in pEGFP-K and pSEAP-K, creating the pEGFP-KP and pSEAP-KP (Fig. 1C). Following this, the identified intron sequences replaced the native introns in pEGFP-KP and pSEAP-KP, resulting in the pEGFP-KPI and pSEAP-KPI (Fig. 1D). Finally, a leader sequence was introduced to generate the pEGFP-KPIL and pSEAP-KPIL (Fig. 1E). The expression vectors were constructed by Anhui General Biotechnology Co., Ltd. The sequences of Kozak, poly A, intron and leader used in this study were provided in the supplement Fig. 1. Fig. 1Transient expression vector used in this study. Using pEGFP and pSEAP as backbone vectors, we systematically engineered a series of constructs. The endogenous Kozak sequences were first replaced, generating pEGFP-K and pSEAP-K. This was followed by the substitution of the native polyA sequences, yielding the -KP variants. Screened intron sequences were then incorporated to create the -KPI constructs. Finally, the addition of a leader sequence produced the ultimate -KPIL versions. CMV: cytomegalovirus promoter; EGFP: enhanced Green Fluorescent Protein; SEAP: secretory alkaline phosphatase; PolyA: polyadenylation Transient expression vector used in this study. Using pEGFP and pSEAP as backbone vectors, we systematically engineered a series of constructs. The endogenous Kozak sequences were first replaced, generating pEGFP-K and pSEAP-K. This was followed by the substitution of the native polyA sequences, yielding the -KP variants. Screened intron sequences were then incorporated to create the -KPI constructs. Finally, the addition of a leader sequence produced the ultimate -KPIL versions. CMV: cytomegalovirus promoter; EGFP: enhanced Green Fluorescent Protein; SEAP: secretory alkaline phosphatase; PolyA: polyadenylation Cell suspension culture and transient transfection CHO-S cells (# A11557-01; Carlsbad, CA, USA) were maintained in suspension culture with CHO Pro Exp® serum-free medium (SFM) (ProteinEasy Biological Co., Ltd., Xinxiang, China) at 37 °C, 120 rpm, and 5% CO2. Prior to transfection, CHO Pro Exp® transfection medium (ProteinEasy Biological Co., Ltd., Xinxiang, China) and PEI solution were pre-warmed at 37 °C. For standard protocol transfection, cells were re-suspended at a cell density of 2 × 106 cells/mL in 6 deep well plate with 2 ml transfection medium. And cells were transfected using 40 kDa linear PEI (PolySciences, Warrington, PA) and 1 µg/ml plasmid DNA (pDNA) at a DNA: PEI mass ratio of 1:5 according to the manufacturer’s instructions. PEI/DNA complexes were formed by adding PEI to diluted pDNA, incubating the mixture at 37 °C for 10 min, and then adding the complexes to the cell suspension. At 24 h post-transfection, add an equal volume (2 ml) of fresh SFM to the culture. The cell density and viability were assessed every day using trypan blue exclusion assay and quantified via count star automated cell counter (Countstar Rigel S2, Shanghai Ruiyu Biotech Co.,Ltd ). Samples were harvested when cell viability dropped below 50%. For high-density suspension transfection, we selected a cell density of 1 × 10⁷ cells/mL, as recommended in the literature (Elshereef et al. 2019). To optimize transfection conditions, we independently adjusted the following parameters: ①DNA amount optimization: Transfections were performed with pDNA concentrations ranging from 3.0 to 7.0 µg/mL, while maintaining a fixed DNA: PEI mass ratio of 1:5. ②DNA: PEI mass ratio optimization: Transfections were carried out with a fixed pDNA concentrations of 4.0 µg/mL and DNA: PEI mass ratios varying from 1:1 to 1:6. ③Repeated transfection optimization: Using a fixed pDNA concentrations of 4.0 µg/mL and a DNA: PEI mass ratio of 1:5, repeat transfections were conducted once or twice at 48 h post-initial transfection. The transfection parameters and procedures are illustrated in Table 1. Table 1The conditions used for each independent optimizationCell Density (cells/mL)Plasmid DNA (µg/mL)DNA: PEI Mass RatioRepeat transfectionsMedium addition at 24 hptCulture vesselDNA Amount1 × 10⁷3.0, 4.0, 5.0, 6.0, 7.01:5None2mL6 deep well plateDNA: PEI Ratio1 × 10⁷4.01:1 to 1:6None2 ml6 deep well plateRepeated transfection1 × 10⁷4.01:5Once or twice2 ml6 deep well plateCollagen and Albumin expression1 × 10⁷4.01:5Once15 ml125 ml Shake flask Table 1The conditions used for each independent optimizationCell Density (cells/mL)Plasmid DNA (µg/mL)DNA: PEI Mass RatioRepeat transfectionsMedium addition at 24 hptCulture vesselDNA Amount1 × 10⁷3.0, 4.0, 5.0, 6.0, 7.01:5None2mL6 deep well plateDNA: PEI Ratio1 × 10⁷4.01:1 to 1:6None2 ml6 deep well plateRepeated transfection1 × 10⁷4.01:5Once or twice2 ml6 deep well plateCollagen and Albumin expression1 × 10⁷4.01:5Once15 ml125 ml Shake flask The conditions used for each independent optimization Flow cytometry Intracellular enhanced green fluorescent protein (EGFP) expression was visualized using a fluorescence inverted microscope (Nikon, Tokyo, Japan). For transfection efficiency assessment and quantitative analysis, cell suspensions were collected, centrifuged at 1,000 rpm for 5 min, and washed three times with ice-cold PBS to remove residual culture medium. The final cell pellet was re-suspended in 500 µL PBS. EGFP fluorescence was then measured using a Thermo Fisher Scientific Attune NxT flow cytometer (Attune NxT, New York, USA) at an event rate of ≤ 600 events per second, acquiring 10,000 events per sample with a 488 nm excitation laser and a 530/30 nm emission filter. Data were analyzed using FlowJo 7.6 software. EGFP expression was quantified as the mean fluorescence intensity (MFI), and transfection efficiency was defined as the percentage of EGFP-positive cells relative to the total cell population at 48 h post transfection. ELISA To quantify secreted embryonic alkaline phosphatase (SEAP) activity, cell supernatants were collected and clarified by sequential centrifugation at 1,000 rpm for 5 min and 13,000 rpm for 10 min to remove cells and debris. SEAP activity was then measured using the Secretory Alkaline Phosphatase ELISA Kit (Beyotime, China) according to the manufacturer’s instructions. Western blotting Supernatants were collected, mixed with loading buffer, and boiled for 5 min. Proteins were separated by 10% SDS-PAGE, transferred onto polyvinylidene difluoride membranes, and blocked with 5% skim milk in TBST for 2 h at room temperature. Following three washes with TBST, the membranes were incubated with 1:10000 HRP-conjugated 6*His, His-Tag mouse Monoclonal antibody (proteintech, Catalog: HRP 66005) for 1.5 h. Protein bands were visualized using enhanced chemiluminescence substrate (Beyotime Biotech Co., Ltd., Shanghai, China), imaged with a Tannon gel imaging system, and quantified using Image J software. Statistical analysis Statistical analysis was performed using SPSS 18.0 software. Data are presented as mean ± standard deviation. SNK q-test was employed for multiple group comparisons, while Dunnett’s t-test was used for pairwise comparisons. A p-value of less than 0.05 was considered statistically significant. Results Screening expression vectors for enhanced transient expression To screen for efficient vectors that enhance transient expression, we first used EGFP and SEAP as intracellular and secreted reporter protein, respectively. For EGFP expression, daily monitoring (i.e. 24, 48, 72, 96, 120, 144 h post-transfection) revealed that cell viability (Fig. 2A) and cell density (Fig. 2B) were not significantly affected by the optimization of vector regulatory elements. However, EGFP fluorescence intensity was visibly higher in the optimized groups compared to the pEGFP control (Fig. 2C). Quantitative analysis confirmed significant increases in mean fluorescence intensity compared to the control pEGFP, pEGFP-KP(1.95-fold ), pEGFP-KPI(3.27-fold), and pEGFP-KPIL( 5.33-fold) (Fig. 2D, p < 0.05). Fig. 2Effect of different expression vector on EGFP transient expression. CHO cells were suspension transfected with different vectors. At 48 post-transfection fluorescence intensity was observed under a fluorescence microscopy. Cell density and viability were monitored daily using an automated cell counter. Cell suspension was harvested at 7 days post-transfection, and EGFP expression was detected by flow cytometry. A Cell viability; B Cell density; C Fluorescence intensity was observed under fluorescence microscopy (Partial fluorescence results); D The EGFP transient expression. Results are expressed as the mean values received from three independent experiments, and standard error of the mean (SEM) is indicated. Compared with pEGFP, *p < 0.05 Effect of different expression vector on EGFP transient expression. CHO cells were suspension transfected with different vectors. At 48 post-transfection fluorescence intensity was observed under a fluorescence microscopy. Cell density and viability were monitored daily using an automated cell counter. Cell suspension was harvested at 7 days post-transfection, and EGFP expression was detected by flow cytometry. A Cell viability; B Cell density; C Fluorescence intensity was observed under fluorescence microscopy (Partial fluorescence results); D The EGFP transient expression. Results are expressed as the mean values received from three independent experiments, and standard error of the mean (SEM) is indicated. Compared with pEGFP, *p < 0.05 Similar to the EGFP expression results, the optimized pSEAP-KP, pSEAP-KPI and pSEAP-KPIL vectors also significantly enhanced SEAP expression in CHO-S cells without affecting cell viability or density (Fig. 3A, B). Quantification analysis via ELISA showed that SEAP activity was increased by 2.36-, 3.35-, and 4.13-fold for the three constructs, respectively, compared to the pSEAP control vector (Fig. 3C, p < 0.05). Among these, pSEAP-KPIL exhibited the highest SEAP expression (Fig. 3C). Consequently, the top-performing vectors pEGFP-KPIL and pSEAP-KPIL were selected for subsequent experiments. Fig. 3Effect of different expression vector on SEAP transient expression. CHO-S cells were suspension transfected with different expression vectors, cell viability (A) and cell density (B) were monitored at 24, 48, 72, 96, 120, 144 h post-transfection. SEAP enzymatic activity was quantified using an ELISA kit, relative expression levels were calculated with the pSEAP vector as the control (C). Data are presented as the mean ± standard error from three independent experiments. Compared with pSEAP, *p < 0.05 Effect of different expression vector on SEAP transient expression. CHO-S cells were suspension transfected with different expression vectors, cell viability (A) and cell density (B) were monitored at 24, 48, 72, 96, 120, 144 h post-transfection. SEAP enzymatic activity was quantified using an ELISA kit, relative expression levels were calculated with the pSEAP vector as the control (C). Data are presented as the mean ± standard error from three independent experiments. Compared with pSEAP, *p < 0.05 Optimization DNA dosage for enhanced transient protein expression To determine the optimal plasmid DNA (pDNA) dosage for the transfection of high-density CHO cell using 40 kDa PEI, we tested concentrations from 3.0 µg/ml to 7.0 µg/ml. Suspension CHO cells were seeded at a density of 1 × 107 cells/ml in a 6- deep well plates and transfected at a fixed DNA: PEI mass ratio of 1:5. Transfection efficiency (percentage of EGFP-positive cells) and cell viability were assessed 48 h post-transfection. A pDNA concentration of 4.0 µg/ml yielded the highest transfection efficiency [(45.13 ± 10.26) %] without significantly compromising cell viability (Fig. 4A). At this optimal concentration, EGFP expression was 1.69-fold higher, and SEAP expression was 1.48-fold higher compared to the 5.0 µg/ml group, where the lowest expression were observed (Fig. 4B, C, p < 0.05).These results confirm 4.0 µg/ml as the optimal pDNA concentration, beyond which recombinant protein expression declines. Consequently, this pDNA concentration was selected for subsequent experiments. Fig. 4Effect of the pDNA amount on transfection efficiency, cell viability and recombinant protein transient expression. Transfection efficiency and cell viability were determined 48 h post-transfection by analyzing the percentage of EGFP-positive cells in the total population and by automated cell counting, respectively. A Transfection efficiency and cell viability; B The EGFP transient expression; C SEAP relative expression. Date are expressed as the mea ± standard error from three independent experiments. Compared with 4 µg group, *p < 0.05 Effect of the pDNA amount on transfection efficiency, cell viability and recombinant protein transient expression. Transfection efficiency and cell viability were determined 48 h post-transfection by analyzing the percentage of EGFP-positive cells in the total population and by automated cell counting, respectively. A Transfection efficiency and cell viability; B The EGFP transient expression; C SEAP relative expression. Date are expressed as the mea ± standard error from three independent experiments. Compared with 4 µg group, *p < 0.05 Optimization of DNA : PEI ratio for enhanced transient expression To determine the optimal DNA: PEI mass ratio for transfecting high-density CHO suspension cells (1 × 10⁷ cells/ml) using 40 kDa PEI, we tested gradient mass ratios from 1:1 to 1:6 at a fixed pDNA concentration of 4 µg/ml. The highest transfection efficiency and EGFP expression were achieved at a 1:5 ratio, with EGFP expression showing a 3.96-fold increase compared to the 1:1 ratio (Fig. 5A, B, p < 0.05). Intermediate ratios of 1:2 to 1:4 also improved expression, yielding 1.31 to 2.63-fold enhancements. Similarly, SEAP activity was also significantly elevated at ratios of 1:2 to 1:5, with a maximum 3.43-fold increase observed at the 1:5 ratio (Fig. 5C, p < 0.05). However, increasing the ratio to 1:6 resulted in reduced the expression of both EGFP and SEAP (Fig. 5B, C). These findings confirm a DNA: PEI mass ratio of 1:5 as optimal for transient recombinant protein expression in high-density CHO suspension cells. Additionally, no significant differences in cell viability or density were observed across the tested ratios (dates not shown). Fig. 5Effect of the DNA : PEI ratio on transfection efficiency, cell viability and recombinant protein transient expression. A Transfection efficiency and cell viability; B The EGFP transient expression; C SEAP relative expression. Date are expressed as the mean ± standard error from three independent experiments. Compared with 1:1 group, *p < 0.05 Effect of the DNA : PEI ratio on transfection efficiency, cell viability and recombinant protein transient expression. A Transfection efficiency and cell viability; B The EGFP transient expression; C SEAP relative expression. Date are expressed as the mean ± standard error from three independent experiments. Compared with 1:1 group, *p < 0.05 Optimization of transfection timing for enhanced transient expression To improve the transfection efficiency of high-density CHO cell we performed one, two, or three rounds of transfection at 48-hour intervals using a fixed DNA: PEI mass ratio of 1:5 and a pDNA concentration of 4 µg/ml. Three rounds of transfection yielded the highest transfection efficiency (76.34 ± 8.45) % with cell viability remaining above 85% despite a slight reduction (Fig. 6A). Relative to a single round of transfection, EGFP fluorescence intensity increased by 2.27-fold and 2.43-fold following two and three rounds, respectively (Fig. 6B, p < 0.05). Similarly, SEAP activity was elevated by 2.13-fold and 2.38-fold (Fig. 6C, p < 0.05). Although repeated transfections improved efficiency, exceeding three rounds significantly compromised cell viability due to cumulative cytotoxicity. Since no statistically significant difference was observed between two and three rounds of transfections, we concluded that two rounds of transfection are optimal for subsequent studies. Fig. 6Effect of the transfection timing on transfection efficiency, cell viability and recombinant protein transient expression. A Transfection efficiency and cell viability; B The EGFP transient expression; C SEAP relative expression. Date are expressed as the mean ± standard error from three independent experiments. Compared with once group, *p < 0.05 Effect of the transfection timing on transfection efficiency, cell viability and recombinant protein transient expression. A Transfection efficiency and cell viability; B The EGFP transient expression; C SEAP relative expression. Date are expressed as the mean ± standard error from three independent experiments. Compared with once group, *p < 0.05 The optimized expression vector and transfection conditions enhanced collagen and albumin transient expression To evaluate our optimized high-density transfection system, we constructed pColIII and pHSA expression vectors by replacing the EGFP gene in the pEGFP-KPIL vector with the recombinant human type III collagen (ColIII) and human serum albumin gene (HSA), respectively (Fig. 7A). Additionally, a 6×His tag was appended to the C-terminus of both HSA and ColIII to facilitate subsequent detection. The standard protocol involved a single transfection of CHO cells seeded at 2 × 10⁶ cells/ml using 3 µg/ml pDNA at a 1:5 DNA: PEI mass ratio. In contrast, the optimized protocol employed two rounds of transfection at a high cell density of 1 × 10⁷ cells/ml, each round utilized 4 µg/ml plasmid and maintained the 1:5 DNA: PEI mass ratio. Cell cultures were harvested when cell viability dropped below 50%, and protein expression was quantified by Western blotting. The optimized system significantly enhanced transient expression, yielding 4.86-fold in recombinant human type III collagen and a 5.50-fold in human serum albumin compared to the standard protocol (un-optimized transfection conditions) (Fig. 7B, C). Fig. 7Effect of optimized transient expression system on recombinant collagen protein and albumin protein expression Effect of optimized transient expression system on recombinant collagen protein and albumin protein expression (A) Schematic of recombinant collagen and albumin expression vectors; (B) Western blot analysis of collagen protein and albumin protein expression levels; (C) The collagen protein and albumin relative expression was analyzed by Image J. In un-optimized group (standard protocol), cells were transfected once at a seeding density 2 × 10⁶ cells/ml using 3 µg/ml pDNA at a DNA: PEI mass ratio of 1:5. The optimized protocol involved two rounds of transfections with cells seeded at 1 × 10⁷ cells/ml, using 4 µg/ml pDNA while maintaining the 1:5 DNA: PEI mass ratio. Protein of interest expression was analyzed by Western blotting. Expression levels were normalized to those of the un-optimized group and are presented as relative fold changes. Error bars represent the standard deviation of triplicate measurements. Discussion CHO cell expression systems are a pivotal platform for recombinant protein production in the biopharmaceutical industry. Transient gene expression (TGE) offers a rapid and flexible alternative to stable expression, typically yielding recombinant proteins within 5–7 days. To improve TGE efficiency in CHO cells, we systematically optimized expression vectors and transfection conditions, implementing a high-density suspension transfection protocol using 40 kDa PEI. The optimized conditions, comprising 4 µg/ml pDNA, a 1:5 DNA: PEI mass ratio, and two rounds of transfection at a seeding density of 1.0 × 10⁷ cells/ml, achieved a transfection efficiency of 76.34% with cell viability maintained over 85%. And this optimized system significantly elevated recombinant protein yields, recombinant human type III collagen and human serum albumin expression level were increased by 4.86-fold and 5.50-fold, respectively. The efficiency of recombinant protein expression is critically dependent on the coordinated function of vector regulatory elements. While the CMV promoter is commonly used in mammalian expression systems, its performance is modulated by associated regulatory sequences, including Kozak sequences, appropriate introns, efficient polyA signals, and effective selection markers (Kawabe et al. 2017). To maximize transient gene expression in CHO cells, we engineered CMV-driven vectors (pEGFP/pSEAP) by optimizing Kozak sequence, polyA signal, intron, and leader sequence. In our previous study, we have screened Kozak, poly A and intron element that are suitable for the CMV promoter (Li et al. 2024; Wang et al. 2022; Xu et al. 2025). In this study, we replaced the native regulatory elements in the CMV-driven transient expression vectors pEGFP and pSEAP with screened Kozak, poly A and intron regulatory elements. The combined optimization of these regulatory elements significantly enhanced protein yields without affecting cell growth or viability. These improvements are attributed to enhanced translation initiation through improved ribosome recognition (Ambrosini et al. 2022), and increased mRNA stability via prolonged half-life and facilitated nuclear export (Huang et al.2023). The incorporation of introns (I) and leader (L) sequences further elevated recombinant protein levels. Introns promoted mRNA maturation and accelerated cytoplasmic transport (Myburgh et al. 2023; Xu et al. 2018), while leader sequences enhanced ribosome scanning and splicing fidelity (Zhang et al. 2025b). Overall, the full combinatorial optimization of regulatory elements boosted EGFP expression by 5.33-fold, a result that was corroborated in the SEAP expression system. Beyond vector design, transfection parameters, including transfection reagent choice, cell density, DNA: PEI ratio, transfection timing, and DNA dosage critically influence recombinant protein expression (González-Domínguez et al. 2019). Although 25 kDa PEI is commonly used for its low toxicity (Godbey et al. 1999; González-Domínguez et al. 2022; Jäger et al. 2013; Raymond et al. 2011). 40 kDa PEI offers superior transfection efficiency and batch stability, making it a promising alternative (Delafosse et al. 2016; Kadlecova et al. 2012; Lu et al.2024). The PEI transfection method is based on the formation of polyplexes between the cationic polymers and negatively charged plasmid DNA. The formation of small, highly positively charged PEI/pDNA polyplexes enhances the entrance of pDNA into cell nuclei (Xie et al. 2013). The PEI performance in terms of the properties of the polyplexes depends on the PEI structure, charge density, and other factors. Compared to 25 kDa PEI, 40 kDa PEI possesses more amine groups, resulting in greater charge density. This elevated charge density promotes stronger electrostatic interactions with the cell membrane, facilitating more effective adsorption of the polymer complexes onto the cell surface and subsequent cellular uptake. Moreover, the 40 kDa PEI used in this study commercially known as Polyethylene “Max” (PEI MAX), 1 H NMR analysis indicated that 40 kDa PEI is 99.8% deacylated, whereas 25 kDa PEI is 97.9% deacylated (i.e. 2.1% of proprionyl group) (Delafosse et al. 2016). The near-complete absence of N-propionyl groups in 40 kDa PEI enables more efficient pDNA binding and confers a higher buffering capacity relative to 25 kDa PEI (Kadlecova et al. 2012; Thomas et al.2005). In contrast, 25 kDa PEI contains residual N-propionyl groups that may limit nucleic acid condensation and endosomal escape (Delafosse et al. 2016). Although the cytotoxicity of 40 kDa PEI may be higher than that of 25 kDa PEI, the extent of toxicity is dependent on the structure, concentration, cell type, and chemical modification of PEI. In this study, we systematically optimized pDNA amount, DNA: PEI ratio and transfection frequency using 40 kDa PEI in high-density CHO suspension cultures to maximize recombinant protein yields and maintain high viability of cells after transfection. We first screened pDNA concentrations ranging from 3.0 to 7.0 µg/mL at a fixed cell density (1 × 10⁷ cells/mL) and DNA: PEI (1:5). The optimal pDNA concentration was determined to be 4.0 µg/mL, which yielding peak transfection efficiency (45.13 ± 10.26%) and maximal recombinant protein production. Higher pDNA concentration reduced both transfection efficiency and protein yield, potentially due to transcriptional resource competition. Plasmid overlord may increase RNA polymerase II stalling near the promoter(Lu et al. 2024), thereby suppressing CMV promoter activity and reducing protein expression(Adelman and Lis 2012). Notably, cell viability remained above 90% throughout the DNA concentration optimization. Optimizing the DNA: PEI mass ratio is critical for efficient gene delivery, as it governs both the biophysical properties of polyplexes and their cellular compatibility (Gupta et al. 2021; Hoon Byeon and Kim 2014). In the present study, a DNA: PEI mass ratio of 1:5 was identified as optimal, yielding a transfection efficiency of approximately 46.17%. When the ratio increases to 1:6, both transfection efficiency and protein production declined, likely due to polyplex aggregation caused by excessive PEI. Conversely, reducing the ratio from 1:4 to 1:1 resulted in a near-linear decrease in transfection efficiency and protein production. While 40 kDa PEI has demonstrated superior performance to 25 kDa PEI in low-density suspension transfection (2–4 × 10⁶ cells/mL) across various cell lines (Delafosse et al. 2016; Kadlecova et al. 2012; Krasnoselska et al. 2021), its application in high-density suspension transfection remains less explored. Most high-density protocols rely on 25 kDa PEI (Liu et al. 2008; Sun et al. 2008), Schmitt et al. (2020) achieved high antibody titers by optimizing plasmid concentration, feeding strategies, and culture at moderate cell densities. Elshereef et al. (2019) reported a transfection efficiency of approximately 73% at 1 × 10⁷ cells/mL using 25 kDa PEI, but this required 17 µg/mL plasmid and 37 µg/mL 25 kDa PEI, with cell viability exceeding 80%. In the present study, we applied 40 kDa PEI for transfection of high-density CHO suspension cells (1 × 10⁷ cells/mL) using 4.0 µg/ml plasmid and a DNA: PEI mass ratio of 1:5, achieved 45% transfection efficiency and over 90% cell viability. Although our transfection efficiency was lower than that reported by Elshereef et al. (2019), our system significant reduced plasmid consumption and PEI concentrations, and improved cell viability due to decreased toxicity, thereby lowering production costs. To further enhance protein yield, we subsequently performed repeated transfections, building upon this optimized baseline. Repeated transfections accompanied by complete medium exchange at 48-hour intervals as described previously (Cervera et al. 2015). This strategy significantly enhanced both transfection efficiency and recombinant protein production. Two and three rounds of transfection achieved efficiencies of approximately 72% and 76%, respectively, and increased protein production by 2- to 3-fold, while maintaining cell viability above 85%. However, beyond three rounds, cumulative cytotoxicity led to a marked decline in cell viability. The observed improvements are consistent with earlier findings, though our system utilized 40 kDa PEI and higher cell density and optimized plasmid dosage compared to the 25 kDa PEI and lower densities and 1 µg plasmid dosage used in prior studies (Elshereef et al. 2019). Enhancement expression through repeated transfection is attributed to an increases the number of producer cells by targeting new cell populations that were not transfected in the initial round, thereby maintaining a high proportion of transfected cells throughout the process (Cervera et al. 2015). Moreover, repeated transfection may enhance expression by continuously supplying plasmids, maintaining plasmid DNA copy number, and stabilizing mRNA (Cervera et al. 2015). However, repeated PEI exposure risks intracellular accumulation, underscoring the need to carefully optimize transfection frequency to balance productivity and cell health. To validate the reproducibility of high-density transfection using 40 kDa PEI, we expressed human type III collagen (ColⅢ) and human serum albumin (HSA) under the established optimized conditions. The consistent results confirm that our optimized CHO cell transient expression system can robustly and reproducibly enhance recombinant protein yields, offering a valuable platform for rapid and efficient recombinant protein expression. Conclusion Optimizing expression vectors and transfection conditions is crucial for maximizing recombinant proteins yields. This study systematically improved CHO transient expression by optimizing vector elements and implementing high-density transfection with 40 kDa PEI. Key parameters, including DNA amount, DNA: PEI mass ratio, and repeated transfection protocols were optimized, resulting in 76% transfection efficiency and over fivefold higher protein expression without loss of cell viability. These gains, achieved through increased transfection efficiency, higher recombinant cell numbers and maintained cell viability in high-density culture (Fig. 8), establish a reliable and effective strategy for transient expression. Fig. 8The mechanism of high-density suspension transfection for enhanced transient recombinant protein production The mechanism of high-density suspension transfection for enhanced transient recombinant protein production Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1